Essential Hypertension Clinical Trial
Official title:
Vedic Medical Astrology in Essential Hypertension: A Double-blind, Placebo-controlled Study
NCT number | NCT03803306 |
Other study ID # | NMP 2172 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | July 12, 2018 |
Est. completion date | January 6, 2019 |
Verified date | January 2019 |
Source | NMP Medical Research Institute |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Previous studies have explored the correlation and impact of astrological events in relation
of diseases, health concerns and relationship between birth chart and disease risk.
Cardiovascular conditions, sleep and fertility were found significantly associated with moon
phase. However, to best of our knowledge no study has documented the impact of astrological
intervention in disease management.
This is a randomised, multi-center, double blind placebo controlled clinical trial with two
parallel arms. This trial aims to evaluate the effectiveness of Vedic medical astrological
intervention for patients with mild to moderate hypertension,with respect to decreasing their
blood pressure and improving their quality of life.
Status | Completed |
Enrollment | 68 |
Est. completion date | January 6, 2019 |
Est. primary completion date | December 15, 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 35 Years to 60 Years |
Eligibility |
Inclusion Criteria: - Patients age between 35 and 60 years old, male and female; - Patients who meet the diagnostic criteria of essential hypertension ( - Patients taking antihypertensive drugs under the supervision of physicians. - Patients having understanding of our study and willing to comply with astrological protocol. - Informed consent Exclusion Criteria: - Patients who have been diagnosed as secondary hypertension or malignant hypertension - Patients with comorbid conditions - Patients with a chronic disease associated or psychiatric conditions which might not suitable for the study - Patients who had been treated with any other alternative or complementary medicine during the previous three months |
Country | Name | City | State |
---|---|---|---|
India | NMP Medical Reserach Institute | Jaipur | Rajasthan |
Lead Sponsor | Collaborator |
---|---|
NMP Medical Research Institute | Swamigal Trust for Vedic Science, India, Warwick Research Services (UK) Ltd |
India,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Average systolic and average diastolic blood pressure | Blood pressure measured by 24-hour ambulatory blood pressure monitoring | change from baseline to 12-weeks | |
Secondary | Changes in patients Quality of life | Health-related quality of life measure by S36 | change from baseline to 12-weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03708601 -
Prognostic Risk of Patients With Essential Hypertension for Cardiovascular Events (PROSPECT)
|
||
Not yet recruiting |
NCT05503953 -
Phase III Study to Evaluate the Efficacy and Safety of AGSAVI in Patients With Essential Hypertension Inadequately Controlled With AGLS
|
Phase 3 | |
Recruiting |
NCT05526703 -
Clinical Trial to Evaluate the Efficacy and Safety of D064 and D701 Combination Therapy
|
Phase 3 | |
Completed |
NCT06395194 -
Effects of Valsartan vs Amlodipine and Low BP on Kidney Outcomes in Essential Hypertension
|
Phase 3 | |
Not yet recruiting |
NCT06418074 -
Effects of Exogenous Ketosis on Renal Function, Renal Perfusion, and Sodium Excretory Capacity
|
N/A | |
Completed |
NCT02890173 -
Study of CS-3150 in Patients With Essential Hypertension
|
Phase 3 | |
Withdrawn |
NCT02096939 -
Microvascular Function in Primary Aldosteronism
|
N/A | |
Completed |
NCT02944734 -
Comparison of Efficacy and Safety of Combination Therapy and Monotherapy of Candesartan and Amlodipine for Dose-Finding in Patients With Essential Hypertension
|
Phase 2 | |
Recruiting |
NCT01956786 -
Efficacy of Amlodipine-Folic Acid Tablets on Reduction of Blood Pressure and Plasma Homocysteine
|
Phase 2/Phase 3 | |
Completed |
NCT02553512 -
Helius in Hypertension-I: The UK Hypertension Registry
|
N/A | |
Completed |
NCT01198249 -
Pharmacokinetic Drug Interactions Between Single and Concomitant Administrations of Amlodipine, Losartan, and Hydrochlorothiazide in Subjects With (Pre)Hypertension
|
Phase 1 | |
Completed |
NCT01001572 -
Efficacy and Safety of Valsartan/Amlodipine in Patients With Mild to Moderate Essential Hypertension
|
Phase 3 | |
Recruiting |
NCT00380289 -
Early Metabolic Changes With Thiazide or Beta Blocker Therapy for Essential Hypertension
|
N/A | |
Completed |
NCT00139698 -
Olmesartan Alone or in Combination With Hydrochlorothiazide in Subjects With Mild to Moderate Essential Hypertension
|
Phase 3 | |
Completed |
NCT00288184 -
Uric Acid in Essential Hypertension in Children
|
Phase 2 | |
Completed |
NCT01289886 -
Fimasartan (BR-A-657) Single Oral Dose in Healthy Subjects
|
Phase 1 | |
Not yet recruiting |
NCT06041529 -
Study to Evaluate the Efficacy and Safety of TEL/AML/CTD in Elderly Patients With Essential Hypertension
|
Phase 4 | |
Completed |
NCT04470830 -
A Study for PMS of AZL-M/CLD FDC in the Treatment of Participants With Essential HTN in South Korea
|
||
Completed |
NCT00758524 -
A Study to Evaluate Efficacy and Safety of LCI699 in Participants With Essential Hypertension
|
Phase 2 | |
Recruiting |
NCT05109013 -
Juvenile Essential Arterial Hypertension and Vascular Function
|